Ghisallo Capital Management LLC I Mab Transaction History

Ghisallo Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$45.28 - $74.5 $1.7 Million - $2.79 Million	-37,500 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$57.18 - $84.43 $2.14 Million - $3.17 Million	37,500 New	37,500 $2.72 Million
Q2 2021 Aug 16, 2021	SELL	$47.86 - $83.95 $20.1 Million - $35.3 Million	-420,675 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$44.38 - $63.97 $18.7 Million - $26.9 Million	420,675 New	420,675 $20.4 Million

15.5M

56.4K

5.8K

Ticker IMAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,098,800
Market Cap $77.3M
Description
I-Mab, a clinical stage biopharmaceutical company, discovers, develops, and commercializes biologics to treat cancer and autoimmune disorders. It is developing Felzartamab, a CD38 antibody that is in Phase 1b/2a for patients with membranous nephropathy; Eftansomatropin alfa, a long-acting human growth hormone, which has completed Phase 3 clinica...

Get notified when there are updates to the investment portfolio of Ghisallo Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ghisallo Capital Management LLC with notifications on news.